Literature DB >> 30235916

Modified Criteria for Diagnosing "Cognitive Frailty".

Chang Won Won1, Yunhwan Lee2, Sunyoung Kim3, Jinho Yoo3, Miji Kim4, Tze-Pin Ng5, Haena Kim6, Sang Joon Son6.   

Abstract

The concept of cognitive frailty has recently been proposed by an International Consensus Group as the presence of physical frailty and cognitive impairment [defined using the Clinical Dementia Ratings (CDR)=0.5], without concurrent dementia. However, CDR is difficult to implement and not often available in epidemiologic studies or busy clinical settings, and an alternative to CDR is required. We suggest an alternative definition of cognitive frailty as: 1) physical frailty, 2) more than 1.5 standard deviation below the mean for age-, gender-, and education-adjusted norms on any cognitive function test (e.g., the Montreal Cognitive assessment test, the Alzheimer's disease assessment scale-cognitive subscale, verbal learning test, Digit Span, Boston Naming Test, Trail Making Test, and Frontal Assessment Battery), and 3) no dependency in instrumental activities of daily living. The redefined criteria for cognitive frailty would be more feasible to implement and thus more applicable in epidemiologic studies and busy clinical settings.

Entities:  

Keywords:  Cognitive frailty; Frailty; Instrumental activities of daily living; Mild cognitive impairment

Year:  2018        PMID: 30235916      PMCID: PMC6166025          DOI: 10.30773/pi.2018.05.22

Source DB:  PubMed          Journal:  Psychiatry Investig        ISSN: 1738-3684            Impact factor:   2.505


LINK BETWEEN PHYSICAL FRAILTY AND COGNITIVE IMPAIRMENT

With increasing life expectancy, frailty and cognitive impairment are being recognized as major threats to healthy aging and quality of life. Frailty in late life predisposes the individual to increased vulnerability to stressors, elevating the risk of disability, institutionalization, and mortality [1]. Physical frailty is quite prevalent in older adults, with a recent systematic review reporting 9.9% of community-dwelling adults aged 65 years and older to have the condition [2]. With age-related cognitive decline, cognitive impairment that does not reach the threshold of dementia is commonly observed in older people, with an increased risk for progression to dementia, contributing to increased disability and healthcare costs [3]. Physical frailty and cognitive impairment often co-occur, with the two conditions being closely interrelated. About 20% of physically frail individuals living in the community are said to be cognitively impaired [4]. Several cohort studies have reported that physical frailty predicts the onset of cognitive decline and incident dementia [5-7]. Cognitive impairment has also been observed to predict physical frailty [8]. Moreover, physical frailty and cognitive impairment appear to reinforce each other, resulting in detrimental outcomes. Frailty when combined with mild cognitive impairment or dementia elevates the risk of poor outcomes [9]. Based on the results of these studies, a concept of “cognitive frailty” has been recently proposed by the International Consensus Group on Cognitive Frailty, organized by the International Academy on Nutrition and Aging (IANA) and the International Association of Gerontology and Geriatrics (IAGG) in France [8]. According to the International Consensus Group, cognitive frailty is defined as the 1) presence of physical frailty and cognitive impairment [Clinical Dementia Rating (CDR)=0.5] and 2) exclusion of concurrent dementia (Figure 1) [10].
Figure 1.

Definition of cognitive frailty by IANA/IAGG International Consensus Group. Cognitive frailty is defined as the presence of physical frailty and cognitive impairment (CDR=0.5) and the exclusion of concurrent dementia. CDR=0.5 includes mild cognitive impairment (MCI) and some dementia, but the exclusion of concurrent dementia limits the boundary to MCI. Cognitive frailty corresponds to the area indicated by the arrow.

The CDR is widely accepted in the clinical setting as a reliable and valid tool for assessing the severity of dementia [11]. However, the CDR is often not available or difficult to implement in epidemiologic studies or busy clinical settings. It is important to note that the CDR is a clinical protocol composed of semi-structured interviews where a clinician or neuropsychologist obtains information from the patient and proxy respondent, and then rates the cognitive performance of the patient in six domains: memory, orientation, judgment and problem solving, community affairs, home and hobbies, and personal care. Furthermore, epidemiologic field surveys sometimes entail recognizing and excluding possible dementia patients in the absence of dementia specialists or neuropsychologists. Therefore, the CDR may not be appropriate for use in epidemiologic studies because of its complexity in measurement and difficulty to implement in the field settings. Thus, we suggest alternative criteria to CDR 0.5 and exclusion of dementia for diagnosing cognitive frailty.

AN ALTERNATIVE TO THE CDR SCORE OF 0.5

Based on the definition by the International Consensus Group of IANA and IAGG, a CDR score 0.5 and the exclusion of concurrent dementia correspond to the concept of mild cognitive impairment (MCI). Many investigators have used a CDR score of 0.5 to define MCI. However, a CDR score of 0.5 is not equivalent to the diagnosis of MCI [12]. In one study, 39.7% of people with a CDR score of 0.5 were found to be demented [13]. Therefore, the diagnosis of MCI and the exclusion of dementia cannot be determined with the CDR score alone. How can we devise an alternative to the CDR score of 0.5 and the exclusion of concurrent dementia? Petersen’s original criteria of MCI used neuropsychological (NP) test performance and operationalized MCI as a score of more than 1.5 standard deviations below that of age-appropriate norms on a measure of episodic memory with performance within the normal range on nonmemory tests [14]. Using a similar approach, the International Working Group on MCI has adapted Petersen’s criteria to take into account differing patterns of cognitive test performance and allowed either memory or nonmemory impairment and single cognitive domain or multiple impaired domains [15]. As to the cognitive assessment for cognitive frailty, the International Consensus Group on Cognitive Frailty by IANA and IAGG have already suggested comprehensive cognitive assessment exploring memory performance as well as other cognitive functions (i.e., executive functions). The panel have also suggested several cognitive tests such as speed of processing test, the Montreal Cognitive assessment (MoCA) test, the Mini Mental state Examination (MMSE) and the Alzheimer’s disease assessment scale-cognitive subscale (ADAS-Cog) [10]. However, the MMSE had low sensitivity (66.01%) for MCI by traditionally accepted cut-off points set at 26/27 [16]. On the other hand, for MoCA test, the best cut-off point is 24/25 with sensitivity of 80.48% and specificity of 81.19% [17]. Among cognitive abilities, the frontal lobe function is important and needs to be assessed for diagnosis of cognitive frailty. This is because cognitively frail individuals might demonstrate significantly more impairments in executive functions than individuals with cognitive impairment but without physical frailty [18]. Executive functions primarily affected in the cognitive frailty were processing speed, selective attention, and mental flexibility, reflecting sub-cortico-frontal cognitive patterned impairments [18].

EXCLUSION OF DEMENTIA

To diagnose cognitive frailty, we should exclude dementia as well. In 2011, a working group charged by the National Institute on Aging and the Alzheimer’s Association revised the diagnostic criteria for MCI [19] (Table 1). The criteria for dementia stipulate that cognitive impairment must be present in two or more domains and must interfere with the abilities to function in daily activities [19,20]. A key criterion for MCI is the absence of dementia. Thus, individuals have to experience cognitive impairment while keeping their functioning abilities intact. Therefore, the preservation of functional activities is essential to differentiating MCI from dementia [15,21].
Table 1.

The revised criteria for mild cognitive impairment by the working group organized by the National Institute on Aging and the Alzheimer’s Association

(1) Cognitive concern reflecting a change in cognition reported by patient or informant or clinician (i.e., historical or observed evidence of decline over time)
(2) Objective evidence of impairment in one or more cognitive domains, typically including memory (i.e., formal or bedside testing to establish level of cognitive function in multiple domains)
(3) Preservation of independence in functional abilities
(4) Not demented

NEWLY SUGGESTED CRITERIA OF COGNITIVE FRAILTY

Based on the above reviews, we propose the new criteria of cognitive frailty as follows (Figure 2).
Figure 2.

Newly suggested definition of cognitive frailty for epidemiologic studies. Any cognitive function test < -1.5 SD of the age-, gender-, and education-adjusted norms mean MCI or Dementia. Dependency in IADL encompasses dementia. The newly suggested definition of cognitive frailty (arrow) is physical frailty and any cognitive function test < -1.5 SD of the age-, gender-, and education-adjusted norm and no dependency in IADL. MCI: mild cognitive impairment, IADL: instrumental activities of daily living.

1) physical frailty; 2) 1.5 SD below the mean for age-, gender-, and education-adjusted norms on any cognitive functioning test (e.g., the MoCA, the ADAS-Cog, verbal learning test, Digit Span, Boston Naming Test, Trail Making Test, and Frontal Assessment Battery); and 3) no dependency in instrumental activities of daily living (IADL); Among IADL items, financial capacity (managing money), telephone use, responsibility for medication, and keeping appointments should be included because these items are particularly more complex tasks requiring high cognitive demands [18]. In conclusion, we propose a new definition of cognitive frailty for wider use in epidemiologic studies and busy clinical settings. The revised criteria need to be tested to determine its value in accurately assessing cognitive frailty and predicting its outcomes.
  21 in total

1.  Mild cognitive impairment: clinical characterization and outcome.

Authors:  R C Petersen; G E Smith; S C Waring; R J Ivnik; E G Tangalos; E Kokmen
Journal:  Arch Neurol       Date:  1999-03

2.  Nontraditional risk factors combine to predict Alzheimer disease and dementia.

Authors:  Xiaowei Song; Arnold Mitnitski; Kenneth Rockwood
Journal:  Neurology       Date:  2011-07-13       Impact factor: 9.910

Review 3.  Frailty and cognitive impairment--a review of the evidence and causal mechanisms.

Authors:  Deirdre A Robertson; George M Savva; Rose Anne Kenny
Journal:  Ageing Res Rev       Date:  2013-07-04       Impact factor: 10.895

4.  Cognitive frailty: rational and definition from an (I.A.N.A./I.A.G.G.) international consensus group.

Authors:  E Kelaiditi; M Cesari; M Canevelli; G Abellan van Kan; P-J Ousset; S Gillette-Guyonnet; P Ritz; F Duveau; M E Soto; V Provencher; F Nourhashemi; A Salvà; P Robert; S Andrieu; Y Rolland; J Touchon; J L Fitten; B Vellas
Journal:  J Nutr Health Aging       Date:  2013-09       Impact factor: 4.075

5.  Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type.

Authors:  J C Morris
Journal:  Int Psychogeriatr       Date:  1997       Impact factor: 3.878

Review 6.  Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-Mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis.

Authors:  Natalia Ciesielska; Remigiusz Sokołowski; Ewelina Mazur; Marta Podhorecka; Anna Polak-Szabela; Kornelia Kędziora-Kornatowska
Journal:  Psychiatr Pol       Date:  2016-10-31       Impact factor: 1.657

7.  Physical frailty is associated with incident mild cognitive impairment in community-based older persons.

Authors:  Patricia A Boyle; Aron S Buchman; Robert S Wilson; Sue E Leurgans; David A Bennett
Journal:  J Am Geriatr Soc       Date:  2010-01-08       Impact factor: 5.562

8.  Frailty consensus: a call to action.

Authors:  John E Morley; Bruno Vellas; G Abellan van Kan; Stefan D Anker; Juergen M Bauer; Roberto Bernabei; Matteo Cesari; W C Chumlea; Wolfram Doehner; Jonathan Evans; Linda P Fried; Jack M Guralnik; Paul R Katz; Theodore K Malmstrom; Roger J McCarter; Luis M Gutierrez Robledo; Ken Rockwood; Stephan von Haehling; Maurits F Vandewoude; Jeremy Walston
Journal:  J Am Med Dir Assoc       Date:  2013-06       Impact factor: 4.669

9.  Improvement of Screening Accuracy of Mini-Mental State Examination for Mild Cognitive Impairment and Non-Alzheimer's Disease Dementia by Supplementation of Verbal Fluency Performance.

Authors:  Jee Wook Kim; Dong Young Lee; Eun Hyun Seo; Bo Kyung Sohn; Young Min Choe; Shin Gyeom Kim; Shin Young Park; Il Han Choo; Jong Chul Youn; Jin Hyeong Jhoo; Ki Woong Kim; Jong Inn Woo
Journal:  Psychiatry Investig       Date:  2014-01-21       Impact factor: 2.505

10.  Neuropsychological Profile of "Cognitive Frailty" Subjects in MAPT Study.

Authors:  J Delrieu; S Andrieu; M Pahor; C Cantet; M Cesari; P J Ousset; T Voisin; B Fougère; S Gillette; I Carrie; B Vellas
Journal:  J Prev Alzheimers Dis       Date:  2016-06
View more
  9 in total

1.  Is Polypharmacy Associated with Cognitive Frailty in the Elderly? Results from the Korean Frailty and Aging Cohort Study.

Authors:  J H Moon; J S Huh; C W Won; H J Kim
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

2.  Sarcopenia Is Associated with Cognitive Impairment Mainly Due to Slow Gait Speed: Results from the Korean Frailty and Aging Cohort Study (KFACS).

Authors:  Miji Kim; Chang Won Won
Journal:  Int J Environ Res Public Health       Date:  2019-04-27       Impact factor: 3.390

3.  Screening for Cognitive Frailty Using Short Cognitive Screening Instruments: Comparison of the Chinese Versions of the MoCA and Qmci Screen.

Authors:  Yangfan Xu; Yangyang Lin; Lingrong Yi; Zhao Li; Xian Li; Yuying Yu; Yuxiao Guo; Yuling Wang; Haoying Jiang; Zhuoming Chen; Anton Svendrovski; Yang Gao; D William Molloy; Rónán O'Caoimh
Journal:  Front Psychol       Date:  2020-04-03

4.  Deviations in Hippocampal Subregion in Older Adults With Cognitive Frailty.

Authors:  Mingyue Wan; Yu Ye; Huiying Lin; Ying Xu; Shengxiang Liang; Rui Xia; Jianquan He; Pingting Qiu; Chengwu Huang; Jing Tao; Lidian Chen; Guohua Zheng
Journal:  Front Aging Neurosci       Date:  2021-01-13       Impact factor: 5.750

5.  Aging metrics incorporating cognitive and physical function capture mortality risk: results from two prospective cohort studies.

Authors:  Xingqi Cao; Chen Chen; Jingyun Zhang; Qian-Li Xue; Emiel O Hoogendijk; Xiaoting Liu; Shujuan Li; Xiaofeng Wang; Yimin Zhu; Zuyun Liu
Journal:  BMC Geriatr       Date:  2022-04-28       Impact factor: 4.070

Review 6.  Exercise interventions for older people with cognitive frailty-a scoping review.

Authors:  Xiaohua Li; Yan Zhang; Yutong Tian; Qingyun Cheng; Yue Gao; Mengke Gao
Journal:  BMC Geriatr       Date:  2022-09-01       Impact factor: 4.070

7.  Calf Circumference as a Screening Tool for Cognitive Frailty in Community-Dwelling Older Adults: The Korean Frailty and Aging Cohort Study (KFACS).

Authors:  Miji Kim; Min Jeong Jeong; Jinho Yoo; Da Young Song; Chang Won Won
Journal:  J Clin Med       Date:  2018-10-08       Impact factor: 4.241

8.  Effects of a traditional Chinese mind-body exercise, Baduanjin, on the physical and cognitive functions in the community of older adults with cognitive frailty: study protocol for a randomised controlled trial.

Authors:  Rui Xia; Mingyue Wan; Huiying Lin; Pingting Qiu; Yu Ye; Jianquan He; Lianhua Yin; Jing Tao; Lidian Chen; Guohua Zheng
Journal:  BMJ Open       Date:  2020-04-15       Impact factor: 2.692

9.  Prevalence of Physical Frailty and Its Multidimensional Risk Factors in Korean Community-Dwelling Older Adults: Findings from Korean Frailty and Aging Cohort Study.

Authors:  Heeeun Jung; Miji Kim; Yunhwan Lee; Chang Won Won
Journal:  Int J Environ Res Public Health       Date:  2020-10-27       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.